Ponesimod is a drug which works by blocking the signals which allow the body’s immune cells to travel to and damage the nerve cells. By preventing the immune cells from damaging the nerves, it is thought this drug will stop the damage which causes MS ‘relapses’. In clinical trials it has been shown that ponesimod reduces the number of ‘relapses’ in people with MS and reduced the amount of damage to the nerves (measured by brain scans) compared to a placebo.
Ponesimod for Relapsing-remitting Multiple Sclerosis
Interventions:
Ponesimod (ACT-128800; RG-3477)
Indications:
Multiple sclerosis (MS)
Therapeutic Areas:
Neurology
Year:
2017